Patent · US Active

1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof

US7956085B2 · kind B2 · utility

45Cited by

1References

15Claims

0Family size

Assignee

Sanofi-Aventis Deutschland GMBH · DE

Inventors

Wendelin Frick · Bad Camberg, DE
Heiner Glombik · Hofheim, DE
Stefan Theis · Frankfurt, DE
Hubert Heuer · Frankfurt am Main, DE
Hans-Ludwig Schaefer · Frankfurt am Main, DE
Werner Kramer · Schwandorf, DE

Key dates

Filing date	May 14, 2009
Grant date	Jun 7, 2011
Priority date	—
Expiry date	Jun 22, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H15/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.